Yeah I agree and feel that CMP doesn't get much credit for holding sales flat in such a difficult environment.
The outlook is for FY21 sales and profit to be higher than FY20 which is commendable considering all of FY21 has been COVID impacted. Yet the share price trades at a significant discount to where it spent most of FY20. This doesn't add up and feels like an opportunity to me.
By the middle of this year the US will be at herd immunity and hopefully that's when things can start to accelerate for CMP again.
Like most I'm hanging in here waiting for a MEG announcement. Fingers crossed they can land another contract soon.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.70M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22900 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.21pm 25/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |
Day chart unavailable